Finance

Beta
Lists
PMVP:NASDAQ
PMV Pharmaceuticals Inc
$1.22
-1.61%
(-0.020) 1D
Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMVP...
Open
$1.24
High
$1.24
Low
$1.20
Mkt. cap
65.06M
Avg. vol.
304.78K
Volume
143.42K
52-wk high
$1.88
52-wk low
$1.02
EPS
-$1.48
Beta
1.33
Shares outstanding
53.33M
No. of employees
54
Open
$1.24
High
$1.24
Low
$1.20
Mkt. cap
65.06M
Avg. vol.
304.78K
Volume
143.42K
52-wk high
$1.88
52-wk low
$1.02
EPS
-$1.48
Beta
1.33
Shares outstanding
53.33M
No. of employees
54
News stories
From sources across the web
About PMV Pharmaceuticals Inc
CEO-
Employees54
Founded2013
Headquarters-
SectorBiotechnology
Websitepmvpharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to PMVP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PMVP in the last 3 months.
Highest
Current $1.22
$5.00 (+309.84%)
Average
$4.50 (+268.85%)
Lowest
$4.00 (+227.87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeff Jones
Oppenheimer
Buy
Maintained
$5.00
+309.8%
05/13/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/12/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$4.00
+227.9%
04/13/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
$4.00
+227.9%
11/13/2025
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.34 / -$0.38
+11.69%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18.40M
18.21M
15.83M
15.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.48M
4.31M
3.42M
3.69M
Operating expense
22.88M
22.52M
19.24M
19.02M
Total operating expenses
22.88M
22.52M
19.24M
19.02M
Operating income
-22.88M
-22.52M
-19.24M
-19.02M
Other non operating income
-16.00K
-23.00K
-1.00K
1.00K
EBT including unusual items
-21.20M
-21.06M
-18.01M
-18.04M
EBT excluding unusual items
-21.20M
-21.06M
-18.01M
-18.04M
Income tax expense
5.00K
-6.00K
26.00K
-
Effective tax rate
-0.02%
0.03%
-0.14%
-
Other operating expenses
-
-
-
-
Net income
-21.21M
-21.06M
-18.04M
-18.04M
Net profit margin
-
-
-
-
Earnings per share
-0.41
-0.40
-0.34
-0.34
Interest and investment income
1.69M
1.48M
1.23M
980.00K
Interest expense
-
-
-
-
Net interest expenses
1.69M
1.48M
1.23M
980.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.85M
-22.49M
-19.21M
-18.98M
Gain or loss from assets sale
34.00K
-1.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer